1126-1140 of 1197
Medicine's Complicity With Big Business: Part 1
Clinician's RoundtableMedicine's Complicity With Big Business: Part 1
Jerome Kassirer, MD
Larry Kaskel, MD
Practice Partnerships: Buy-Ins and Buy-Outs
Clinician's RoundtablePractice Partnerships: Buy-Ins and Buy-Outs
Michael Ryan, MBA
Larry Kaskel, MD
What is the Value of Your Medical Practice?
Clinician's RoundtableWhat is the Value of Your Medical Practice?
Michael Ryan, MBA
Larry Kaskel, MD
Larry Kaskel, MD
Roberta Greenspan
Larry Kaskel, MD
Roberta Greenspan
Predicition and Prevention for Type 1 Diabetes
Clinician's RoundtablePredicition and Prevention for Type 1 Diabetes
William V. Tamborlane, MD
Bill Rutenberg, MD
- advertisement
Supporting Patients with Type 1 Diabetes.
Clinician's RoundtableSupporting Patients with Type 1 Diabetes.
William V. Tamborlane, MD
Bill Rutenberg, MD
State of the Art Treatment of Type 1 Diabetes
Clinician's RoundtableState of the Art Treatment of Type 1 Diabetes
William V. Tamborlane, MD
Bill Rutenberg, MD
William V. Tamborlane, MD
Bill Rutenberg, MD
Outpacing the FDA: Finding Adverse Drug Reactions
Clinician's RoundtableOutpacing the FDA: Finding Adverse Drug Reactions
Charles Bennett, MD
Paul Raeburn
Trudy Lieberman
Paul Raeburn
Jeff Feldman, MBA
Larry Kaskel, MD
- advertisement
Debora Spar, PhD
Maurice Pickard, MD
Type I diabetes - How close are we to a cure?
Clinician's RoundtableType I diabetes - How close are we to a cure?
Jerry Nadler, MD
Bruce Bloom, DDS, JD
Type I diabetes - How close are we to a cure?
Clinician's RoundtableType I diabetes - How close are we to a cure?
Bruce Bloom, DDS, JD
Raghu Mirmira, MD,PhD
